Menu
Recruiting NCT07401212

GUTLINK4KIDS Intervention

No phase Interventional Temperament Sleep Cognition Emotion Regulation

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Prebiotic powder, Placebo.
Who it may be relevant to
Registry conditions: Temperament, Sleep, Cognition, Emotion Regulation. Basic parameters: 3 years — 5 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United Kingdom
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

The Impact of Chronic Consumption of Prebiotics on Cognitive and Affective Outcomes, Gut Microbiome Diversity and Composition in 3-5 Year Olds: a Double-blind Placebo-controlled, Parallel-groups Randomised Controlled Trial

Overview

This study aims to investigate the chronic effects of prebiotic consumption on cognitive, behavioural and gut microbiome outcomes in children aged 3-5 years.

Detailed description

This study will employ a double-blind, randomised, placebo-controlled parallel design to investigate the chronic effects of 8-week-long prebiotic consumption on cognitive, behavioural, and gut microbiome, outcomes in 3-5-year-old children with insufficient fibre intake (less than the average 10.4g/day in 18-47-month-olds and less than 12.6g/day in 48-60-month-olds). One hundred and six participants will be randomised to Intervention or Placebo groups where they will be consuming 5g of prebiotic fibre or 5g of placebo (matched placebo powder) per day for 8-weeks. Outcome measures will be acquired before and after a 8-week chronic supplementation. These will include cognitive and behavioural outcomes of the parents and children. In addition, stool samples will be collected at the baseline and at week 8 to assess microbiome diversity and composition. Additionally, after 4-weeks of wash-out, at 12 weeks, parents will be asked to completed online questionnaires assessing cognitive and behavioural outcome of their children.

Interventions

  • Dietary supplement Prebiotic powder
    5g of prebiotic fibre
  • Dietary supplement Placebo
    5g of placebo

Primary outcome measures

  • Child Behaviour Checklist Ages 1.5-5 [Time frame: This measure will be taken at baseline (pre intervention), week 8 (post intervention) and week 12 (after 4-week wash-out)]
Secondary outcome measures (5)
  • Emotion Regulation Skills Questionnaire [Time frame: This measure will be taken at baseline (pre intervention), week 8 (post intervention) and week 12 (after 4-week wash-out)]
  • Childhood Autism Spectrum Test [Time frame: This measure will be taken at baseline (pre intervention), week 8 (post intervention) and week 12 (after 4-week wash-out)]
  • Bristol Stool Chart [Time frame: This measure will be taken at baseline (pre intervention), week 8 (post intervention) and week 12 (after 4-week wash-out)]
  • Gut microbiome diversity [Time frame: This measure will be taken at baseline (pre intervention) and week 8 (post intervention).]
  • Gut microbiome composition [Time frame: This measure will be taken at baseline (pre intervention) and week 8 (post intervention).]

Eligibility criteria

Inclusion criteria

  • Parents (18 years and over) of generally healthy children aged 3-5-years-old (36-71 months) with lower dietary fibre intake than the recommended daily amount (10.4g/day in 18-47-month-olds and less than 12.6g/day in 48-60-month-olds).

Exclusion criteria

  • Children with a significant acute or chronic co-existing illness (including inflammatory bowel disease, functional gastrointestinal disorders, coeliac disease etc, neurodevelopmental, immunological, psychiatric, or metabolic disorders.
  • Children who have taken any pre/probiotic supplements or antibiotic treatment within the 4 weeks prior to enrolment.
  • Children with food allergies and intolerances

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Quadruple blind
Primary purpose
Basic science

Study locations

United Kingdom · 1 center
  • University of Reading, School of Psychology and Clinical Languages — Reading

Identifiers

NCT: NCT07401212 · UREC25_38

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗